Importantly, among these H + patients, seven were negative for the six prognostically informative AML mutations (FLT3-ITD, NPM1, biallelic CEBPA, ASXL1, RUNX1, and TP53) (Fig. 5b). This evidence concerns the gene TP53 and acute myeloid leukemia.